Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06368765 · ClinicalTrials.gov registry record · NA
Oral Rehydration Solution and Dehydration Recovery
A NA study, sponsored by Abbott Nutrition.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT06368765: Clinical Trial NA study, sponsored by Abbott Nutrition.
NCT06368765 is a NA study that was terminated before completion, run by Abbott Nutrition. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06368765, a NA study, was terminated before completion, sponsored by Abbott Nutrition.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a prospective, randomized, controlled, blinded, crossover, study to evaluate the effects of an oral hydration solution.
Primary Outcome
Calculated Change in Plasma Volume
Interventions
- OTHER Water
- OTHER Oral Rehydration Solution (ORS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2024-07-08 |
| Est. Completion | 2024-10-17 |
| Phase | NA |
Why NCT06368765 stopped before completion
NCT06368765 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT06368765 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06368765 about?
NCT06368765 is a clinical study titled "Oral Rehydration Solution and Dehydration Recovery". This is a prospective, randomized, controlled, blinded, crossover, study to evaluate the effects of an oral hydration solution.
What is the current status of trial NCT06368765?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2024-07-08. Estimated completion is 2024-10-17.
What interventions are being tested in trial NCT06368765?
The interventions under investigation include: Water (OTHER), Oral Rehydration Solution (ORS) (OTHER).
Who is sponsoring clinical trial NCT06368765?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06368765's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI